Raj Chovatiya, MD, PhD: Atopic Dermatitis Patient Counseling for Moisturization

Dr. Raj Chovatiya emphasizes the value of pairing moisturizers with topical or systemic therapies to improve outcomes for all severities of atopic dermatitis.

Topics Covered:

  • Importance of moisturization in AD treatment plans

  • Enhancing outcomes with combination therapy

  • Patient counseling tips for adherence

  • Moisturizer use across disease severities

 

Explore Related Resources:

Utilizing Topical Treatments for Atopic Dermatitis

Reaching for the Stars in Atopic Dermatitis

MORE EXPERT PERSPECTIVES IN ATOPIC DERMATITIS:

Raj Chovatiya, MD, PhD, MSCI: Advancements in Topical Therapy for Atopic Dermatitis

Raj Chovatiya, MD, PhD, MSCI, an associate professor at Rosalind Franklin University of Medicine and Science Chicago Medical School and founder and director of the

David Seiter, FNP-C: Rapid Relief for Atopic Dermatitis Flares

David Seiter, FNP-C, shares a patient success story involving a teenage patient with severe atopic dermatitis that achieved complete skin clearance within one week after

Christopher Bunick, MD, PhD: Rapid Itch Relief with Upadacitinib vs. Dupilumab in Atopic Dermatitis

Christopher Bunick, MD, PhD, an associate professor of dermatology at Yale School of Medicine in New Haven, Connecticut, discusses a poster presentation comparing the itch

George Han, MD, PhD: Advancing Atopic Dermatitis Care: Early Use of Topical JAK Inhibitors
George Han, MD, PhD, discusses the evolving treatment strategies for patients with atopic dermatitis.
Kara Mudd DMSc, PA-C: Use of Ruxolitinib in Pediatric Patients with Atopic Dermatitis
Kara Mudd reviews findings from the Phase 3 TRuE-AD3 study evaluating topical ruxolitinib in children aged 2 to <12 years with atopic dermatitis. The discussion
Mona Shahriari, MD: Removal of Black Box Warnings Change Considerations for Hormonal Therapy in Atopic Dermatitis

Dr. Shahriari reviews the FDA’s decision to remove certain “black box” warnings for hormone replacement therapy (HRT) and discusses how this shift may influence treatment

Emma Guttman-Yassky, MD: Evaluating Long-term Efficacy of Upadacitinib in Patients with Atopic Dermatitis

Dr. Johann Gudjonsson discusses how spesolimab may reduce low-grade inflammation between flares in patients with generalized pustular psoriasis (GPP). Topics Covered: Subclinical inflammation in GPP

Lisa Swanson, MD: Topical Therapies for the Treatment of Atopic Dermatitis

Dr. Lisa Swanson highlights three effective nonsteroidal topical therapies for managing atopic dermatitis in both pediatric and adult patients. Topics Covered: Nonsteroidal topical options for

Raj Chovatiya, MD, PhD: Maintaining Optimal Treatment Targets with Upadacitinib for Patients with Atopic Dermatitis

Dr. Raj Chovatiya presents long-term data on upadacitinib’s ability to maintain skin clearance and itch relief in atopic dermatitis patients over 140 weeks. Topics Covered: